ArticleTropical animal health and production2025
Effect of Azolla pinnata inclusion in corn silage on digestibility, ruminal fermentation, blood parameters and growth performance of Barki male lambs.
Article in Tropical animal health and production, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Azolla (Azolla pinnata- Ap) is a novel and unconventional source of animal feed, which enhances the nutritional value and reduces feeding costs. Azolla has not been used in animal feeding as silage before, so the aim of this study was to investigate the impact of increasing levels of Azolla as a partial component in corn silage on the nutrient digestibility, rumen fermentation, blood parameters, and growth performance of Barki male lambs. In ensilage processes, different levels of wilted Azolla were mixed in chopped corn plants (without cobs) in four treatments, as follows: (1) 100% chopped corn without Azolla; (2) 95% chopped corn plus 5% Azolla; (3) 90% chopped corn plus 10% Azolla; (4) 85% chopped corn plus 15% Azolla. A growth trial was conducted using twenty-eight healthy Barki male lambs (8 months old, average initial body weight of 31.25 ± 0.60 kg), which were divided into four groups (n = 7). Lambs in each group were fed one of the four types of silage produced as a single diet at 3% dry matter of body weight. Results revealed that the inclusion of Azolla in corn silage significantly (P˂0.05) increased crude protein content and enhanced physical and fermentation characteristics. All nutrients digestibility were improved in corn silage mixed with different levels of Azolla compared to corn silage (P˂0.05). The concentrations of ammonia and total volatile fatty acid in the rumen reached their highest values at 3 h post-feeding. They were significantly higher (P = 0.004 and P = 0.045, respectively) for lamb groups fed any of three varieties of Azolla-corn silage than lambs fed corn silage. The highest (P˂0.05) values of body weight at 60 and 90 day, total body gain and average daily gain were recorded in lambs fed silage contained 15% Azolla, followed by those fed silage contained 10% and 5% Azolla, while the lowest values were recorded in lambs fed control silage. Lambs fed silage contained 10% and 10% Azolla had the greatest total protein and albumin values (P = 0.027 and P = 0.021, respectively), followed by lambs fed silage contained 5% Azolla, while those fed corn silage had the lowest values. In conclusion, the physical, chemical and fermentation characteristics of silage of Azolla corn mixture were enhanced. They can be used successfully in Barki male lamb rations, with beneficial effects on digestibility, nutritive value, rumen fermentation and growth performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.